Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of huntington's disease

Stem Cells

Volumn 32, Issue 2, 2014, Pages 500-509

  Rossignol, Julien ^a,b   Fink, Kyle ^a   Davis, Kendra ^a   Clerc, Steven ^a   Crane, Andrew ^a   Matchynski, Jessica ^a   Lowrance, Steven ^a   Bombard, Matthew ^a   Dekorver, Nicholas ^a   Lescaudron, Laurent ^c,d,e   Dunbar, Gary L ^a,b  

^a Children's Hospital of Michigan   (United States)

^b Field Neurosciences Institute   (United States)

^c INSERM   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ DE NANTES   (France)

Author keywords

Mesenchymal stem cells; Neural stem cells; Rat model; Stem cell microenvironment interactions; Stem cell transplantation

Indexed keywords

MESENCHYMAL STEM CELLS; NEURAL STEM CELLS; RAT MODEL; STEM CELL MICROENVIRONMENT INTERACTIONS; STEM CELL TRANSPLANTATION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; HUMANS; HUNTINGTON DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NEURAL STEM CELLS; RATS; RATS, TRANSGENIC;

EID: 84894515770     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1508     Document Type: Article

References (46)

1. The Huntington's Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993;72: 971-983.
2. Graveland GA, Williams RS, DiFiglia M. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 1985;227: 770-773.
3. Vonsattel JP, DiFiglia M. Huntington disease. J Neuropathol Exp Neurol 1998;57: 369-384.
4. Harrower T, Barker RA. Cell therapies for neurological disease-from bench to clinic to bench. Expert Opin Biol Ther 2005;5: 289-291.
5. Bachoud-Levi A-C, Gaura V, Brugiè res P et al. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: A long-term follow-up study. Lancet Neurol 2006;5: 303-309.
6. Bachoud-Levi A-C. Neural grafts in Huntington's disease: Viability after 10 years. Lancet Neurol 2009;8: 979-981.
7. Reuter I, Tai YF, Pavese N et al. Longterm clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. J Neurol Neurosurg Psychiatry 2008;79: 948-951.
8. Capetian P, Knoth R, Maciaczyk J et al. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation. Neuroscience 2009;160: 661-675.
9. Krystkowiak P, Gaura V, Labalette M et al. Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. PLoS One 2007;2: e166.
10. Cicchetti F, Saporta S, Hauser RA et al. Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc Natl Acad Sci USA 2009; 106: 12483-12488.
11. Svendsen C. Adult versus embryonic stem cells: Which is the way forward? Trends Neurosci 2000;23: 450.
12. Dominici M, Blanc K Le, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8: 315-317.
13. Mareschi K, Novara M, Rustichelli D et al. Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K1 channel types. Exp Hematol 2006;34: 1563-1572.
14. Neuhuber B, Gallo G, Howard L et al. Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: Disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. J Neurosci Res 2004;77: 192-204.
15. Azizi SA, Stokes D, Augelli BJ et al. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc Natl Acad Sci USA 1998;95: 3908-3913.
16. Mezey E, Chandross KJ, Harta G et al. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000;290: 1779-1782.
17. Lepski G, Jannes CE, Strauss B et al. Survival and neuronal differentiation of mesenchymal stem cells transplanted into the rodent brain are dependent upon microenvironment. Tissue Eng Part A 2010;16: 2769-2782.
18. Rossignol J, Boyer C, Thinard R et al. Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. J Cell Mol Med 2009;13: 2547-2558.
19. Rossignol J, Boyer C, Levè que X et al. Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: Morphological and behavioral outcomes. Behav Brain Res 2011; 217: 369-378.
20. Lescaudron L, Unni D, Dunbar GL. Autologous adult bone marrow stem cell transplantation in an animal model of Huntington's disease: Behavioral and morphological outcomes. Int J Neurosci 2003; 113: 945-956.
21. Blanc K Le, Tammik C, Rosendahl K et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31: 890-896.
22. Dunbar GL, Sandstrom MI, Rossignol J et al. Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: Use of gangliosides, substituted pyrimidines, and mesenchymal stem cells. Behav Cogn Neurosci Rev 2006;5: 63-79.
23. Lois C, Alvarez-Buylla A. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci USA 1993; 90: 2074-2077.
24. Gage FH, Kempermann G, Palmer TD et al. Multipotent progenitor cells in the adult dentate gyrus. J Neurobiol 1998;36: 249-266.
25. Klassen H, Imfeld KL, Ray J et al. The immunological properties of adult hippocampal progenitor cells. Vision Res 2003;43: 947-956.
26. Sun D, Gugliotta M, Rolfe A et al. Sustained survival and maturation of adult neural stem/progenitor cells after transplantation into the injured brain. J Neurotrauma 2011;28: 961-972.
27. Döbrössy MD, Dunnett SB. Environmental enrichment affects striatal graft morphology and functional recovery. Eur J Neurosci 2004;19: 159-168.
28. Martin-Ibanez R, Urban N, Sergent-Tanguy S et al. Interplay of leukemia inhibitory factor and retinoic acid on neural differentiation of mouse embryonic stem cells. J Neurosci Res 2007;85: 2686-2701.
29. Johann V, Schiefer J, Sass C et al. Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease. Exp Brain Res 2007;177: 458-470.
30. Dziewczapolski G, Lie DC, Ray J et al. Survival and differentiation of adult ratderived neural progenitor cells transplanted to the striatum of hemiparkinsonian rats. Exp Neurol 2003;183: 653-664.
31. Shim J-W, Park C-H, Bae Y-C et al. Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using Nurr1 overexpression. Stem Cells 2007;25: 1252-1262.
32. Chen K, Hughes SM, Connor B. Neural progenitor cells derived from the adult rat subventricular zone: Characterization and transplantation. Cell Transplant 2007;16: 799-810.
33. von Hörsten S, Schmitt I, Nguyen HP et al. Transgenic rat model of Huntington's disease. Hum Mol Genet 2003;12: 617-624.
34. Richardson RM, Broaddus WC, Holloway KL et al. Grafts of adult subependymal zone neuronal progenitor cells rescue hemiparkinsonian behavioral decline. Brain Res 2005; 1032: 11-22.
35. Vazey EM, Chen K, Hughes SM et al. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease. Exp Neurol 2006;199: 384-396.
36. Bao X, Wei J, Feng M et al. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res 2011; 1367: 103-113.
37. Bouchez G, Sensebe L, Vourc'h P et al. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochem Int 2008;52: 1332-1342.
38. Joyce N, Annett G, Wirthlin L et al. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 2010; 5: 933-946.
39. Bantubungi K, Blum D, Cuvelier L et al. Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease. Mol Cell Neurosci 2008;37: 454-470.
40. Cicchetti F, Gross RE, Bulte JWM et al. Dual-modality in vivo monitoring of subventricular zone stem cell migration and metabolism. Contrast Media Mol Imaging 2007;2: 130-138.
41. Meyerrose T, Olson S, Pontow S et al. Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev 2010;62: 1167-1174.
42. Herrera DG, Garcia-Verdugo JM, Alvarez-Buylla A. Adult-derived neural precursors transplanted into multiple regions in the adult brain. Ann Neurol 1999;46: 867-877.
43. Blandini F, Cova L, Armentero M-T et al. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant 2010;19: 203-217.
44. Black IB, Woodbury D. Adult rat and human bone marrow stromal stem cells differentiate into neurons. Blood Cells Mol Dis 2001;27: 632-636.
45. Woodbury D, Schwarz EJ, Prockop DJ et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000;61: 364-370.
46. Yang M, Stull ND, Berk MA et al. Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat. Exp Neurol 2002;177: 50-60.